Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
NCT05481931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 756
Last updated 2026-05-14
Summary
Non-interventional PASS of NUCEIVA for the treatment of moderate-to-severe glabellar lines to provide additional characterisation of the long-term safety of NUCEIVA in the real-world clinical practice setting.
Conditions
- Glabellar Frown Lines
Interventions
- DRUG
-
prabotulinumtoxinA
Botulinum toxin Type A powder for solution for injection
Sponsors & Collaborators
-
Avania
collaborator INDUSTRY -
Evolus, Inc.
lead INDUSTRY
Principal Investigators
-
Rui Avelar · Evolus, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-15
- Primary Completion
- 2026-02-04
- Completion
- 2026-02-04
Countries
- Germany
Study Locations
More Related Trials
-
The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
NCT06124794 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
NCT06834789 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Moderate to Severe Glabellar Lines
NCT04249583 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
NCT03004248 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
NCT05167864 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03960957 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248893 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05321979 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03736928 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
NCT04143815 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
NCT05059587 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
NCT04146584 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014635 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
NCT01391312 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
NCT05364580 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Retreatment
NCT02984878 ·Status: COMPLETED ·Phase: NA
-
Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds
NCT03611491 ·Status: COMPLETED ·Phase: NA
-
MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
NCT03721016 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids
NCT06104514 ·Status: COMPLETED ·Phase: NA
-
Sculptra Aesthetic Post-Approval Study
NCT02425943 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
NCT04247074 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00888914 ·Status: COMPLETED ·Phase: PHASE2
-
JUVÉDERM VOLUX® for Chin Retrusion in China
NCT04559984 ·Status: COMPLETED ·Phase: PHASE3